I am not sure that it is not an advantage to continue with the quinidine after the normal rhythm has returned, with a view to preventing the recurrence of fibrillation. In paroxysmal fibrillation and simple paroxysmal tachyeardia, I give quinidine in small doses, 0'2 grm. three or four times daily for months. This may be good practice in all cases: I have certainly not seen any harmful results from quinidine given in this way.
I have had one case of sudden death after 2'0 grm. of quinidine had been given in the usual way. The patient was a woman aged 50 with moderate enlargement, no valve disease, and a ventricular rate of 140-150 after slight effort. There were no signs of venous engorgement and no breathlessness at rest. The nurse had left her reading a book and quite comfortable; when the nurse returned a quarter of an hour later, she found her dead, lying in the same position. There was no autopsy. Death may have been due to ventricular fibrillation. I have seen the same thing happen with digitalis. I do not know whether quinidine was responsible for death in this case.
Signs of embolism have not occurred in any of my cases. I have always given quinidine to private patients with auricular fibrillation in a nursing home. Few patients require longer than a week's stay. If at the end of a week the normal rhythm has not returned, I dismiss the case as a failure. I insist on absolute rest in bed with the avoidance of all unnecessary movements. These precautions are taken to prevent giddinessa symptom of which complaint is often made-and to ward off syncopal attacks which are particularly alarming to the patient, the nursing staff, and sometimes to the physician. The giddiness I attribute to the rapid heart actiona quinidine effect-and the syncopal attacks are probably vagal in origin.
A test dose of 02 grm. quinidine sulphate is given on the day of admission, and if there is no idiosyncrasy for the drug, on the following day I give four doses of 0 4 grm. at intervals of three hours. On the third day I add an extra cachet, and from this time onwards the patient has 2 grm. daily. It is, of course, not possible to observe the effect of quinidine on the auricular rate without a galvanometer and chest leads. This is really not a serious handicap. With a return of the rhythm to normal it is easy to recognize the change with a stethoscope. Occasionally, the heart is irregular after auricular fibrillation has ceased from extrasystoles. It is best in these cases to make certain of the type of irregularity by taking a polygraphic tracing.
Dr. IUiescu has kindly given me the figures to date of cases treated in the clinic of Sir Thomas Lewis at University College Hospital. Quinidine was given in forty-two cases of established auricular fibrillation. The patients reverted to their normal condition in twenty-five (or 59 per cent.) of these cases. Ten have remained normal; seven for more than a year. Fibrillation returned in 50 per cent. of the cases with a normal rhythm restored within two weeks. Apparently, in these cases the successes and failures seemed to be quite independent of age, venous congestion, infection, type of valve disease, or degree of enlargement. Those with a long history of fibrillation were restored to their normal state as quickly as others with fibrillation of short duration.
Dr. F. PARKES WEBER said he wished to draw attention to a possible danger in connexion with quinidine treatment for auricular fibrillation.
A well-built Englishman, aged 60, was admitted to hospital with cardiac irregularity typical of auricular fibrillation. Swelling had been noticed in the legs in the evenings.
The heart was slightly enlarged to the left, but there was no definite murmur. The hepatic dullness extended too far downwards. The treatment, at first, was by preparations of the digitalis class, including intravenous injections of Boehringer's strophanthin; but the cardiac irregularity persisted till quinidine sulphate was given (in doses of 02 grm. thrice daily). Then, within a week, the pulse became perfectly regular (confirmed by careful sphygmograms). By ordinary examination there seemed to be nothing wrong with the man, excepting that his liver dullness still extended somewhat too far downwards; but his blood-serum was found to give a strongly positive Wassermann reaction. It was then ascertained that he had had a chancre thirty-four years ago, for which he had been treated, but he could not remember having had any symptoms of secondary syphilis. His wife had had one miscarriage, not long after marriage, and had never become pregnant again. Antisyphilitic treatment was commenced. The auricular fibrillation in this case may have been due to cardiac syphilis, and no history of rheumatic fever could be obtained.
There seemed to be a real danger in such cases that the disappearance of the auricular fibrillation under quinidine treatment might occasionally lead to the overlooking of syphilis as the main cause of the cardiac trouble. Thus, the cardiac disease might be allowed to progress, owing to the syphilitic factor remaining unrecognized, until antisyphilitic treatment was no longer of any avail.
Dr. Weber said he was indebted to his colleague, Dr. E. Schwarz, for the history of the first part of the above case, during a time when he (Dr. Weber) had been away from London.
Dr. B. T. PARSONS-SMITH said that the subject of quinidine therapy was of extreme importance, for in spite of very extensive investigation the indications and usage of the drug had not yet emerged from their probationary stages.
His opinion was that quinidine was a valuable and at the same time a somewhat dangerous drug, in essence a powerful depressant and poison to cardiac muscle tissue, and in some degree to the autonomic nervous system controlling the heart's mechanism. Certain unfortunate features were invariably associated with quinidine therapy: First, the uncertainty of its action, which would appear to depend in great measure upon the inability to assess during life the varying types of pathological anatomy which underlay auricular fibrillation, and, secondly, the possibility of serious disturbances of rhythm, ventricular tachycardia, premature contractions, ventricular standstill, &c., during the transition stages. He (Dr. Parsons-Smith) particularly emphasized the remarks of Dr. Drury that quinidine therapy should, for the present, only be employed in those circumstances under which strict observation and graphic control of the cardiac mechanism could be conveniently practised, and this would involve full in-patient treatment in every case.
Extreme care should be exercised in the selection of cases for treatment by quinidine. Those patients in whom the fibrillation had been of recent onset and in whom the signs of myocardial degeneration were not advanced in degree, should be especially chosen; and at the same time cases of long standing with signs of gross failure should not be wholly excluded if there was any reasonable chance of subjective improvement following the reversion from fibrillation to the normal auriculo-ventricular rhythm.
He thought it very necessary to bear in mind that quinidine was by no means a substitute for digitalis in auricular fibrillation; the respective values
